Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 3,695.00
-55.00 (-1.47%)
Oct 10, 2025, 3:30 PM KST
Cellid, Market Cap
Cellid, has a market cap or net worth of 109.01 billion as of October 10, 2025. Its market cap has decreased by -2.53% in one year.
Market Cap
109.01B
Enterprise Value
113.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,695.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 109.01B, a decrease of -77.40%. That is a compound annual growth rate of -20.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 109.01B | 2.09% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | 394.74B | 50.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |